Discordance in HER2 Status in Gastro-esophageal Adenocarcinomas: A Systematic Review and Meta-analysis

Trastuzumab combined with chemotherapy is standard of care for HER2 positive advanced gastro-esophageal cancers. The reported prevalence of HER2 discordance between primary tumors and corresponding metastases varies, hampering uniform patient selection for HER2 targeted therapy. This meta-analysis e...

Descripción completa

Detalles Bibliográficos
Autores principales: Creemers, A., ter Veer, E., de Waal, L., Lodder, P., Hooijer, G. K. J., van Grieken, N. C. T., Bijlsma, M. F., Meijer, S. L., van Oijen, M. G. H., van Laarhoven, H. W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466678/
https://www.ncbi.nlm.nih.gov/pubmed/28600510
http://dx.doi.org/10.1038/s41598-017-03304-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466678/
https://www.ncbi.nlm.nih.gov/pubmed/28600510
http://dx.doi.org/10.1038/s41598-017-03304-9

Ejemplares similares